[HTML][HTML] Change in androgenic status and cardiometabolic profile of middle-aged women with polycystic ovary syndrome
K van der Ham, MPH Koster, BK Velthuis… - Journal of Clinical …, 2023 - mdpi.com
Understanding the cardiovascular disease (CVD) risk for women with polycystic ovary
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
K van der Ham, MPH Koster… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Understanding the cardiovascular disease (CVD) risk for women with polycystic ovary
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
[HTML][HTML] Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
K van der Ham, MPH Koster, BK Velthuis… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Understanding the cardiovascular disease (CVD) risk for women with polycystic ovary
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
K van der Ham, M Koster, B Velthuis… - Journal of Clinical …, 2023 - europepmc.org
Understanding the cardiovascular disease (CVD) risk for women with polycystic ovary
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
[PDF][PDF] Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
K van der Ham, MPH Koster, BK Velthuis, RPJ Budde… - J. Clin. Med, 2023 - pure.eur.nl
Understanding the cardiovascular disease (CVD) risk for women with polycystic ovary
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome.
K van der Ham, MPH Koster… - Journal of Clinical …, 2023 - search.ebscohost.com
Understanding the cardiovascular disease (CVD) risk for women with polycystic ovary
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
K van der Ham, MPH Koster… - Journal of Clinical …, 2023 - search.proquest.com
Understanding the cardiovascular disease (CVD) risk for women with polycystic ovary
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome.
K van der Ham, MPH Koster, BK Velthuis… - Journal of Clinical …, 2023 - europepmc.org
Understanding the cardiovascular disease (CVD) risk for women with polycystic ovary
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
[PDF][PDF] Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
K van der Ham, MPH Koster, BK Velthuis, RPJ Budde… - J. Clin. Med, 2023 - pure.eur.nl
Understanding the cardiovascular disease (CVD) risk for women with polycystic ovary
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …
syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the …